Dextran sulfate

DRUG3 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

HIV Infections

Phase 1

A Study of Dextran Sulfate in HIV-Infected Patients and in Patients With AIDS or AIDS Related Complex (ARC)

CompletedNCT00001009

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

End: 1990-04-30Target: 60Updated: 2021-11-01

Single Dose Pharmacokinetics of Oral Dextran Sulfate (UA001) and Intravenous Dextran Sulfate in Healthy Volunteers

CompletedNCT00000690

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

End: 1989-10-31Target: 6Updated: 2021-11-02

Unknown Phase

Continuous High-Dose Intravenous Dextran Sulfate in Human Immunodeficiency Virus-Infected Individuals

CompletedNCT00000684

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

End: 1991-04-30Target: 10Updated: 2021-11-03